Armata Pharmaceuticals, Inc. (ARMP) Financials
ARMP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 69.8 million | 381.4 million |
| Dec. 31, 2025 | 76.9 million | 295.5 million |
| Sept. 30, 2025 | 89.5 million | 185.1 million |
| June 30, 2025 | 80.8 million | 150.3 million |
ARMP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -5.8 million | 1.1 million |
| Dec. 31, 2025 | -6.7 million | 632000 |
| Sept. 30, 2025 | -4.5 million | 622000 |
| June 30, 2025 | -7.4 million | 575000 |
ARMP Net Income
No data available :(
ARMP Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 4.8 million | 342.9 million | 26.2 million |
| Dec. 31, 2025 | 8.7 million | 256.9 million | 26.5 million |
| Sept. 30, 2025 | 14.8 million | 15.2 million | 31.4 million |
| June 30, 2025 | 4.3 million | - | 31.6 million |
ARMP Shares Outstanding
ARMP Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 63000 | 6.1 million | 3.5 million | - |
| Dec. 31, 2025 | 52000 | 6.1 million | 3.4 million | - |
| Sept. 30, 2025 | 242000 | 5.8 million | 3.1 million | - |
| June 30, 2025 | 149000 | 6.4 million | 2.6 million | - |
ARMP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 789000 | 457000 |
| Dec. 31, 2025 | 1.1 million | 418000 |
| Sept. 30, 2025 | 1.2 million | 370000 |
| June 30, 2025 | 2.2 million | 366000 |
ARMP
Price: $5.06
52 week price:
Payout Ratio Range:
Earnings Per Share: -7.78 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 6136
Market Capitalization: 194.9 million